Application of tetra-arsenic hexoxide composition in preparation of pharmaceutical composition for preventing or treating cancer
The present invention relates to a use of a tetraarsenic hexoxide (As4O6) composition in the preparation of a pharmaceutical composition for the prevention or treatment of cancer, the tetraarsenic hexoxide (As4O6) composition comprising 99% or more of a polymorphic substance a of tetraarsenic hexoxi...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
01.09.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a use of a tetraarsenic hexoxide (As4O6) composition in the preparation of a pharmaceutical composition for the prevention or treatment of cancer, the tetraarsenic hexoxide (As4O6) composition comprising 99% or more of a polymorphic substance a of tetraarsenic hexoxide having the following characteristics i to iii; i, unit cell constants: alpha = beta = gamma = 90 degrees, ii, As-O bond length: iii, O-As-O bond angle: 98.36 degrees. The composition of the present invention exhibits an excellent cancer cell proliferation inhibiting effect, and thus can be effectively used as an anticancer agent.
本发明涉及一种六氧化四砷(As4O6)组合物在制备用于预防或治疗癌的药物组合物中的用途,其中,所述六氧化四砷(As4O6)组合物包含99%以上的具有下述i至iii的特性的六氧化四砷的多晶型物a;i、单位细胞常数:α=β=γ=90°,ii、As-O键长:iii、O-As-O键角:98.36°。本发明的组合物显示出优异的癌细胞增殖抑制效果,从而能够有效地用作抗癌剂。 |
---|---|
Bibliography: | Application Number: CN202310686518 |